Neuroscience
A fuller report from The New York Times:
F.D.A. Sees Promise in Alzheimer’s Imaging Drug
By GINA KOLATA
The New York Times
Published: January 20, 2011
"A committee voted that the agency should approve the first test that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person."
Read the full article
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
From The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By THE ASSOCIATED PRESS Published: January 20, 2011 Filed at 5:40 p.m. ESTWASHINGTON (AP) — A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical...
- Upcoming: Alzheimer's: Fda Advisory Committee Meeting (20-21 January 2011)
From the FDA (.pdfs of briefing material is available at the link below): January 20-21, 2011: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement Read the full announcementAgenda "On January 20, 2011, the committee will...
- Dilemma Of Ever Earlier Diagnosis Of Alzheimer's Disease
Gina Kolata has written a fine piece inThe New York Times: Early Tests for Alzheimer’s Pose Diagnosis Dilemma By GINA KOLATA The New York Times Published: December 17, 2010 "Since there is no treatment, doctors wonder if they should tell people, years...
- Alzheimer's Disease: Rethinking Things?
A very readable piece from Gina Kolata of the New York Times: Doubt on Tactic in Alzheimer’s Battle By GINA KOLATA The New York Times Published: August 18, 2010 "The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and...
- Alzheimer's Disease: A-beta And Immune System
Old Enemy Might Help to Prevent Alzheimer’s By GINA KOLATA The New York Times Published: March 8, 2010 "Harvard researchers are taking a new look at beta amyloid, which was thought to be a chief villain in Alzheimer’s whose function was that of a...
Neuroscience
FDA: PCNS Drugs Advisory Committee Results for Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times:
F.D.A. Sees Promise in Alzheimer’s Imaging Drug
By GINA KOLATA
The New York Times
Published: January 20, 2011
"A committee voted that the agency should approve the first test that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person."
Read the full article
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
From The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By THE ASSOCIATED PRESS Published: January 20, 2011 Filed at 5:40 p.m. ESTWASHINGTON (AP) — A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical...
- Upcoming: Alzheimer's: Fda Advisory Committee Meeting (20-21 January 2011)
From the FDA (.pdfs of briefing material is available at the link below): January 20-21, 2011: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement Read the full announcementAgenda "On January 20, 2011, the committee will...
- Dilemma Of Ever Earlier Diagnosis Of Alzheimer's Disease
Gina Kolata has written a fine piece inThe New York Times: Early Tests for Alzheimer’s Pose Diagnosis Dilemma By GINA KOLATA The New York Times Published: December 17, 2010 "Since there is no treatment, doctors wonder if they should tell people, years...
- Alzheimer's Disease: Rethinking Things?
A very readable piece from Gina Kolata of the New York Times: Doubt on Tactic in Alzheimer’s Battle By GINA KOLATA The New York Times Published: August 18, 2010 "The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and...
- Alzheimer's Disease: A-beta And Immune System
Old Enemy Might Help to Prevent Alzheimer’s By GINA KOLATA The New York Times Published: March 8, 2010 "Harvard researchers are taking a new look at beta amyloid, which was thought to be a chief villain in Alzheimer’s whose function was that of a...